A Study to Assess Tolerability of the Trivalent Recombinant Vaccine in Individuals Aged 18 and Older Using the Vaccinees Perception of Injection Questionnaire

NCT06765187 · clinicaltrials.gov ↗

COMPLETED

Status

1007

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza Immunization
Health Volunteers

Interventions

BIOLOGICAL: Trivalent Recombinant Influenza Vaccine

Sponsor

Sanofi